Pfizer suspends sale and distribution of its life-saving antibiotics in India due to manufacturing process deviation
American pharmaceutical giant Pfizer has temporarily suspended the sale and distribution of its antibiotics, Magnex, Magnex Forte, Zosyn, and Magnamycin, that are used as life-saving injections, with immediate effect.
In a letter dated May 16, 2023, Pfizer issued a alert asking stockists, distributors, and hospitals, to seize use and distribution of the injections, citing a “deviation in the manufacturing process.”
Comments
Leave A CommentStart the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login